Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis
骡DNA损伤反应和肿瘤发生的分子机制
基本信息
- 批准号:8196709
- 负责人:
- 金额:$ 30.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:Adaptor Signaling ProteinAffinityAffinity ChromatographyApoptosisApoptoticBH3 DomainBindingBinding SitesBiochemicalBiological AssayBiological ProcessCancer EtiologyCaspaseCell Cycle ArrestCell Cycle CheckpointCell DeathCell ExtractsCell divisionCell physiologyCell-Free SystemCellsCessation of lifeConflict (Psychology)DNADNA DamageDNA damage checkpointDNA lesionDoseEmbryoEnzymesEquilibriumEventExposure toFibroblastsFractionationGeneticGenotoxic StressHumanIn VitroKnockout MiceLinkMCL1 proteinMalignant NeoplasmsMapsMediatingMitochondriaModificationMolecularOncogenicPathway interactionsPatientsPhenotypePhosphorylationPhosphotransferasesPhysiological ProcessesPlayProteinsRNA InterferenceRegulationRoleSerineSignal TransductionSpecificityStructureStructure-Activity RelationshipSurfaceSystemTestingTherapeutic InterventionThreonineTimeTranslationsTumor SuppressionTyrosineUbiquitinUbiquitinationanticancer researchbasecancer cellcell injuryclinically significantcytochrome ccytotoxicdesigninsightknockout genemulticatalytic endopeptidase complexnoveloverexpressionprotein protein interactionreconstitutionrelease factorrepairedresearch studyresponsetumorigenesisubiquitin ligaseubiquitin-protein ligase
项目摘要
Project Summary
Cancer remains a major killer that impacts a large number of new patients every year. One
leading reason for cancer is an inappropriate response to DNA damage. Upon DNA damage, the cell will
initiate apoptosis through the mitochondria apparatus when DNA damage is beyond repair. Once this cell death
pathway is triggered, cytotoxic factors are released from mitochondria to activate caspases that induce
apoptosis. An impaired apoptotic potential of damaged cells leads to continued cell division without restriction
that frequently develops into cancer. Indeed, mis-regulation of apoptosis is associated with many cancers.
Understanding the molecular mechanisms that regulate DNA damage signals and how they are transmitted to
mitochondria to initiate apoptosis is therefore important for cancer research. Biochemical approaches are
utilized to reconstitute DNA damage-induced apoptosis. Degradation of Mcl-1, a key anti-death protein, is
required to trigger cytochrome c release from mitochondria upon DNA damage. Mcl-1 is degraded through the
ubiquitin-proteasome pathway. In the ubiquitin-proteasome system, the ubiquitin ligases determine the
specificity and timing of substrates destruction. A biochemical assay was established to search for such enzyme
from human cell extracts, and a novel ubiquitin ligase Mule (Mcl-1 ubiquitin ligase e3) was cloned. Mule
promotes ubiquitin modification of Mcl-1 through direct interaction through a BH3 domain, and Mule is
indispensable for Mcl-1 mediated apoptotic pathway. Besides Mcl-1, Mule also ubiquitinates other substrates
including p53, thus adding another intriguing link to the apoptosis pathway. In this proposal, the mechanism by
which Mule activation and the differential regulation of Mule target different substrates in response to DNA
damage signals will be investigated. The biological function of Mule in DNA damage response will be studied
in Aim 1. Our newly generated Mule knockout mouse embryonic fibroblast cells will be utilized to study the
function of Mule in DNA damage induced apoptosis and cell cycle checkpoints. We will also investigate the
structure and function relationship of Mule, especially the requirement of the ubiquitin ligase activity of Mule
for its function in DNA damage response in this aim. We will characterize the ubiquitination and degradation of
Mcl-1 and p53 by Mule in Aim 2. Ubiquitin chain formation, E3 activity (Mule versus Mdm2), the contribution
of Mcl-1 and p53 in Mule-dependent DNA damage response, and regulatory mechanisms of Mcl-1 and p53
ubiquitination will be investigated in this aim. In Aim 3, we will further characterize the interaction of Mule
with its substrates; especially map the binding site of p53 to Mule. We will study how the interaction between
Mule and substrates are regulated by DNA damage. More importantly, we will search for novel protein factors
modulating Mule acitivity through tandem affinity purification. In Aim 4, we will put more focus on post-
translation modification of Mule, especially phosphorylation of Mule in DNA damage response and discuss
potential mechanisms involved in it. These experiments should reveal novel mechanisms mediating DNA
damage signals and how they are transduced through Mule, thereby providing fundamental insights into
regulatory networks controlling apoptosis and DNA damage response. A mechanistic understanding of this
pathway will help us decipher how apoptosis is deregulated in cancer and potentially identify new targets for
therapeutic intervention.
项目摘要
癌症仍然是每年影响大量新患者的主要杀手。一
癌症的主要原因是对DNA损伤的不适当反应。一旦DNA受损,细胞就会
当DNA损伤无法修复时,通过线粒体装置启动细胞凋亡。一旦细胞死亡
当细胞凋亡通路被触发时,细胞毒性因子从线粒体释放以激活半胱天冬酶,
凋亡受损细胞的凋亡潜能受损导致细胞继续分裂而不受限制
经常发展成癌症。事实上,细胞凋亡的错误调节与许多癌症有关。
了解调节DNA损伤信号的分子机制以及它们如何被传递到
因此,线粒体启动细胞凋亡对于癌症研究是重要的。生物化学方法是
用于重建DNA损伤诱导的细胞凋亡。Mcl-1是一种关键的抗死亡蛋白,
所需的触发细胞色素c释放线粒体DNA损伤。Mcl-1是通过
泛素-蛋白酶体途径在泛素-蛋白酶体系统中,泛素连接酶决定了蛋白质的结构。
底物破坏的特异性和时机。建立了一种生物化学方法来寻找这种酶
从人细胞提取物中克隆了一种新的泛素连接酶Mule(Mcl-1 ubiquitin ligase e3)。骡子
通过BH 3结构域的直接相互作用促进Mcl-1的泛素修饰,Mule是
在Mcl-1介导的凋亡途径中不可或缺。除了Mcl-1,Mule还泛素化其他底物
包括p53,从而增加了另一个有趣的连接到细胞凋亡途径。在该提案中,
其中Mule激活和Mule的差异调节响应于DNA而靶向不同的底物,
将调查损坏信号。Mule在DNA损伤反应中的生物学功能
目标1。我们新产生的Mule基因敲除小鼠胚胎成纤维细胞将用于研究
Mule在DNA损伤诱导的细胞凋亡和细胞周期检查点中的作用。我们还将调查
Mule的结构和功能关系,特别是对Mule的泛素连接酶活性的要求
在DNA损伤反应中的作用。我们将描述的泛素化和降解的
Mule在Aim 2中的Mcl-1和p53。泛素链形成,E3活性(Mule与Mdm 2),
Mcl-1和p53在骡依赖性DNA损伤反应中的作用及其调控机制
泛素化将在这一目标进行研究。在目标3中,我们将进一步描述Mule的交互作用
尤其是p53与Mule的结合位点。我们将研究
Mule和底物受DNA损伤调控。更重要的是,我们将寻找新的蛋白质因子
通过串联亲和纯化调节Mule活性。在目标4中,我们将更加注重后
Mule的翻译修饰,特别是Mule的磷酸化在DNA损伤反应中的作用,并讨论了
这些实验应该揭示新的机制,介导DNA
损伤信号以及它们是如何通过Mule传导的,从而为以下方面提供了基本的见解:
调控网络控制细胞凋亡和DNA损伤反应。机械地理解这个
细胞凋亡通路将帮助我们破译细胞凋亡在癌症中是如何失调的,并有可能确定新的靶点。
治疗干预
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Qing Zhong其他文献
Qing Zhong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Qing Zhong', 18)}}的其他基金
Biochemical Dissection and Reconstitution of Autophagic Membrane Fusion
自噬膜融合的生化解剖与重建
- 批准号:
9004982 - 财政年份:2015
- 资助金额:
$ 30.29万 - 项目类别:
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis
骡DNA损伤反应和肿瘤发生的分子机制
- 批准号:
8769278 - 财政年份:2009
- 资助金额:
$ 30.29万 - 项目类别:
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis
骡DNA损伤反应和肿瘤发生的分子机制
- 批准号:
8384853 - 财政年份:2009
- 资助金额:
$ 30.29万 - 项目类别:
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis
骡DNA损伤反应和肿瘤发生的分子机制
- 批准号:
7584403 - 财政年份:2009
- 资助金额:
$ 30.29万 - 项目类别:
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis
骡DNA损伤反应和肿瘤发生的分子机制
- 批准号:
7753898 - 财政年份:2009
- 资助金额:
$ 30.29万 - 项目类别:
Molecular Mechanism of Mule in DNA Damage Response and Tumorigenesis
骡DNA损伤反应和肿瘤发生的分子机制
- 批准号:
7989407 - 财政年份:2009
- 资助金额:
$ 30.29万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 30.29万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 30.29万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 30.29万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 30.29万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 30.29万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 30.29万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 30.29万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 30.29万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 30.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 30.29万 - 项目类别:
Collaborative Research and Development Grants